Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Emergent Health Corp (OP: EMGE )

0.0010 UNCHANGED
Streaming Delayed Price Updated: 3:50 PM EST, Nov 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Emergent Health Corp

< Previous 1 2 3 Next >
Apollo Biowellness, Inc./Resonate Blends, Inc., Provides Corporate Update Following Closing of Share Exchange Agreement
North Bergen, New Jersey--(Newsfile Corp. - May 13, 2024) - Apollo Biowellness, Inc., /Resonate Blends, Inc. (OTC Pink: KOAN) ("Resonate... 
Via Newsfile
Resonate Blends Executes a Share Exchange Agreement With Emergent Health Corp.
Via ACCESSWIRE
Emergent Health and Apollo Biowellness Announce Strategic Collaboration
Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced today that it will be collaborating with Apollo Biowellness, Inc., the... 
Via TheNewswire.com
Topics Initial Public Offering
Exposures Securities Market
Emergent Health and Apollo Biowellness Announce Strategic Collaboration
Former L'Oréal President and Emergent’s CEO promoted to Emergent Chairman of the Board successor Announced 
Via News Direct
Topics Initial Public Offering
Exposures Securities Market
Emergent Health Executes Term Sheet and Engagement Letter with Boustead Securities to roll up its Subsidiary, Evolutionary Biologics and other regenerative medicine and products companies
Emergent Health Executes Term Sheet and Engagement Letter with Boustead Securities to roll up its Subsidiary, Evolutionary Biologics and other regenerative medicine and products companies 
Via News Direct
Topics Initial Public Offering Regulatory Compliance
Exposures Legal Product Safety Regulatory
Emergent Health Executes Term Sheet and Engagement Letter with Boustead Securities to roll up its Subsidiary, Evolutionary Biologics and other regenerative medicine and products companies
Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced that it has executed a Term Sheet and Engagement Letter with Boustead... 
Via TheNewswire.com
Topics Initial Public Offering Regulatory Compliance
Exposures Legal Product Safety Regulatory
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Reports Quarter over Quarter Revenue Increase of Over 2300%
Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced revenues of $340,531 for the quarter ended March 31, 2023, as compared to... 
Via TheNewswire.com
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Reports Quarter over Quarter Revenue Increase of Over 2300%
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Reports Quarter over Quarter Revenue Increase of Over 2300% 
Via News Direct
Emergent Health Subsidiary Evolutionary Biologics Executes Product Manufacturing Agreement with Major Player in the Regenerative Medicine Space
Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced that its subsidiary Evolutionary Biologics, Inc. (“EvoBio”), a developer,... 
Via TheNewswire.com
Topics Initial Public Offering
Exposures Securities Market
Emergent Health Subsidiary Evolutionary Biologics Executes Product Manufacturing Agreement with Major Player in the Regenerative Medicine Space
Expected to Generate at least $2 Million in New Revenue 
Via News Direct
Emergent Health Subsidiary PharmaZu Retains BF Borgers to Audit its Financial Statement as required by the Engagement Letter with Boustead Securities
Emergent Health Subsidiary PharmaZu Retains BF Borgers to Audit its Financial Statement as required by the Engagement Letter with Boustead Securities 
Via News Direct
Topics Initial Public Offering
Exposures Securities Market
Emergent Health Subsidiary PharmaZu Retains BF Borgers to Audit its Financial Statement as required by the Engagement Letter with Boustead Securities
Via TheNewswire.com
Topics Initial Public Offering
Exposures Securities Market
Emergent Health to spin out subsidiary PharmaZu to its Shareholders pursuant to an IPO underwritten by a Nationally Recognized Investment Banking Firm
Emergent Health to spin out subsidiary PharmaZu to its Shareholders pursuant to an IPO underwritten by a Nationally Recognized Investment Banking Firm 
Via News Direct
Topics Initial Public Offering
Exposures Securities Market
Emergent Health to spin out subsidiary PharmaZu to its Shareholders pursuant to an IPO underwritten by a Nationally Recognized Investment Banking Firm
Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced today that it has executed a Term Sheet for a firm committed underwriting... 
Via TheNewswire.com
Topics Initial Public Offering
Exposures Securities Market
Emergent Health Announces Its Return to the “Pink Current Information” Tier on OTC Markets
Emergent Health Announces Its Return to the “Pink Current Information” Tier on OTC Markets 
Via News Direct
Emergent Health Announces Its Return to the “Pink Current Information” Tier on OTC Markets
Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space, is pleased to announce that it has regained its “Pink Current Information” status... 
Via TheNewswire.com
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Corp. Reports Year to Year Revenue Increase of Over 380% and Quarter to Quarter Revenue Increase of Over 100%
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Corp. Reports Year to Year Revenue Increase of Over 380% and Quarter to Quarter Revenue Increase of Over 100% 
Via News Direct
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Corp. Reports Year to Year Revenue Increase of Over 380% and Quarter to Quarter Revenue Increase of Over 100%
Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced today announced revenues of $373,406 for the quarter ended December 31, 2022... 
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property
Emergent Announces 'Month in Review' with CEO Jim Morrison
Via ACCESSWIRE
Emergent Health Announces Revenue Forecast of $16 Million & Introduces ‘MAXIMUS Men’s Health’
Via ACCESSWIRE
Emergent Health (EMGE) Completes Acquisition of Nanosthetic - Adding $3.5 Million to its Growing Revenue Streams
Via ACCESSWIRE
Emergent Health (EMGE) Executes "Letter of Intent" to Acquire Privately Held Company with a total of $5.4 Million in Current Revenues
Via ACCESSWIRE
(EMGE) Emergent Health Enters Acquisition Talks with Revenue-Producing Medical Company
Via ACCESSWIRE
Emergent Health Announces that Retail Power Hitter and Former Kraft Foods Director of National Accounts, Charlie McMenamin, Plans Product Placements in Nation's Biggest Retail Companies
Via ACCESSWIRE
Emergent Projects $3.5 Million in Revenues With Acquisition of Nanosthetic Corp. Fueling Evolutionary Biologics
Via ACCESSWIRE
Emergent Health Appoints Former Kraft Foods Director of National Accounts Charlie McMenamin to Its Board of Directors
Via ACCESSWIRE
Emergent Executes "Letter of Intent" to Acquire Nanosthetic, a Biologics Company That Manufacturers Products to be Sold and Marketed by Evolutionary Biologics
Via ACCESSWIRE
Emergent Intends to Become a Fully Reporting SEC Issuer and List its Shares on the OTCQB
Via ACCESSWIRE
Emergent Reports Revenues of Approximately $408,000 for the Quarter Ended December 31st, 2022, as Compared to Approximately $185,000 for the Quarter Ended September 30, 2022, an Increase of Over 100%
Via ACCESSWIRE
Emergent Subsidiary "PharmaZu" Launches E-Commerce Online Platform Entering the Estimated $8.5 Billion-Dollar Online Pet Medicine Industry
Via ACCESSWIRE
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.